Roux-en-Y gastric bypass
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Roux-en-Y gastric bypass is procedure used to treat obesity.
General
- Treatment for obesity.
- Mortality ~0.15%.[1]
- A segment of small bowel is excised as part of the procedure.
Microscopic
Features:
- Normal small bowel wall.
Note:
- May have increased intraepithelial lymphocytes.[2]
Sign out
Small Bowel, Excision During Gastric Bypass: - Small bowel wall within normal limits.
Small Bowel, Excision during Roux-en-Y Gastric Bypass: - Small bowel wall within normal limits.
IELs present
Small Bowel, Excision during Gastric Bypass: - Small bowel wall with increased intraepithelial lymphocytes, otherwise within normal limits, see comment. Comment: The increased intraepithelial lymphocytes are likely explained by obesity; however, other causes (such as infection, inflammatory bowel disease and celiac disease) should be considered within the clinical context.
See also
References
- ↑ Benotti, P.; Wood, GC.; Winegar, DA.; Petrick, AT.; Still, CD.; Argyropoulos, G.; Gerhard, GS. (Jan 2014). "Risk factors associated with mortality after Roux-en-Y gastric bypass surgery.". Ann Surg 259 (1): 123-30. doi:10.1097/SLA.0b013e31828a0ee4. PMID 23470583.
- ↑ Harpaz, N.; Levi, GS.; Yurovitsky, A.; Kini, S. (Mar 2007). "Intraepithelial lymphocytosis in architecturally normal small intestinal mucosa: association with morbid obesity.". Arch Pathol Lab Med 131 (3): 344; author reply 344. doi:10.1043/1543-2165(2007)131[344b:IR]2.0.CO;2. PMID 17516730.